Clinical Trial Update: Study of Hepalatide in Chronic Hepatitis D(CHD) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for Hepalatan in chronic hepatitis D shows completed status; no efficacy results provided in snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Hepalatide

Snippet

Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. | Conditions: Chronic Hepatitis D Infection | Phase 2 | Status: COMPLETED